The biotech and pharmaceutical industry experienced significant developments in the second quarter of 2025, including advancements in ai innovations and notable merger and acquisition moves. However, biotech startup funding reportedly declined during this period. The industry's overall outlook and trends may be influenced by various factors, including policy challenges and shifting global market dynamics.